Current Topics in Medicinal Chemistry

Editorial [ Hot Topic: DPP-IV as a Target in Medicinal Chemistry and Drug Discovery (Guest Editor: Dr. Jens-Uwe Peters) ]
pp. 545-545(1)
Author: Peters, Jens-Uwe

Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes
pp. 547-555(9)
Authors: Sebokova, Elena; Christ, Andreas D.; Boehringer, Markus; Mizrahi, Jacques

Discovery of JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.
pp. 557-568(12)
Authors: Thornberry, Nancy A.; Weber, Ann E.

Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.
pp. 569-578(10)
Authors: Szczepankiewicz, Bruce G.; Kurukulasuriya, Ravi

11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
pp. 579-595(17)
Author: Peters, Jens-Uwe

Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)
pp. 597-608(12)
Authors: Ferraris, Dana; Belyakov, Sergei; Li, Weixing; Oliver, Eddie; Ko, Yao-Sen; Calvin, David; Lautar, Susan; Thomas, Bert; Rojas, Camilo

Molecular Recognition of Ligands in Dipeptidyl Peptidase IV
pp. 609-620(12)
Authors: Kuhn, Bernd; Hennig, Michael; Mattei, Patrizio

Prolyl Peptidases Related to Dipeptidyl Peptidase IV: Potential of Specific Inhibitors in Drug Discovery.
pp. 621-635(15)
Authors: Van der Veken, Pieter; Haemers, Achiel; Augustyns, Koen

Molecule of the Month
pp. 637-637(1)
Author: Lindsley, Craig W.